Ernexa Therapeutics, Inc. (ERNA)
2.34
-0.15
(-6.02%)
USD |
NASDAQ |
Oct 09, 16:00
2.34
0.00 (0.00%)
After-Hours: 16:58
Ernexa Therapeutics Market Cap : 2.738M for Oct. 9, 2026
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| October 08, 2026 | 2.913M |
| October 07, 2026 | 2.796M |
| October 06, 2026 | 2.615M |
| October 05, 2026 | 3.159M |
| October 02, 2026 | 3.463M |
| October 01, 2026 | 3.463M |
| September 30, 2026 | 3.744M |
| September 29, 2026 | 3.697M |
| September 28, 2026 | 4.060M |
| September 25, 2026 | 4.031M |
| September 24, 2026 | 4.235M |
| September 23, 2026 | 4.270M |
| September 22, 2026 | 4.446M |
| September 21, 2026 | 4.633M |
| September 18, 2026 | 4.481M |
| September 17, 2026 | 4.399M |
| September 16, 2026 | 4.575M |
| September 15, 2026 | 4.774M |
| September 14, 2026 | 4.996M |
| September 11, 2026 | 4.873M |
| September 10, 2026 | 4.703M |
| September 09, 2026 | 4.703M |
| September 08, 2026 | 4.902M |
| September 04, 2026 | 5.043M |
| September 03, 2026 | 5.300M |
| Date | Value |
|---|---|
| September 02, 2026 | 5.312M |
| September 01, 2026 | 5.090M |
| August 31, 2026 | 5.347M |
| August 28, 2026 | 5.347M |
| August 27, 2026 | 5.54M |
| August 26, 2026 | 5.721M |
| August 25, 2026 | 5.762M |
| August 24, 2026 | 5.891M |
| August 21, 2026 | 5.686M |
| August 20, 2026 | 5.288M |
| August 19, 2026 | 5.183M |
| August 18, 2026 | 4.972M |
| August 17, 2026 | 4.750M |
| August 14, 2026 | 4.996M |
| August 13, 2026 | 5.031M |
| August 12, 2026 | 5.171M |
| August 11, 2026 | 5.136M |
| August 10, 2026 | 5.300M |
| August 07, 2026 | 4.926M |
| August 06, 2026 | 5.101M |
| August 05, 2026 | 4.797M |
| August 04, 2026 | 5.171M |
| August 03, 2026 | 4.023M |
| July 31, 2026 | 3.824M |
| July 30, 2026 | 4.046M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Cerenome, Inc. | 14.11M |
| ACADIA Pharmaceuticals, Inc. | 3.405B |
| Alnylam Pharmaceuticals, Inc. | 31.10B |
| Savara, Inc. | 1.012B |
| Vericel Corp. | 2.051B |
Market Cap Related Metrics
| Price to Book Value | 0.8558 |
| Price | 2.34 |
| Earnings Yield | -808.7% |